NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/06/2022
Back to search
Official data from USPTO
ADAPTIVE BIOTECHNOLOGIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/21/2023
Classification
Registered
Trademark type
Combined
Nice classes
42, 44
Filing date
01/11/2021
Registration date
12/06/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/06/2022
Last transaction
04/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2021
First use in commerce
01/01/2021
Drawing code
5
Owner type
03
Owner location
Seattle, WA, US
Examiner
MICHELI, ANGELA M
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "Adaptive" with the letter "A" being capitalized and the word "biotechnologies" in lowercase lettering.
Holders and representatives
Holders
A. C. (pessoa física)
Adaptive Biotechnologies Corp.
Representatives
Hoang-chi Truong PATENT LAW WORKS LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual diseasethe analysisevaluationreporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expressioncancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapyoncologyhematologyauto-immune disordersinfectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services
Class 44
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual diseasethe analysisevaluationreporting of those test results to help healthcare professionals determine a patient's clinical diagnosisthe effectiveness of patient treatmentsto revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of person
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/06/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/29/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/28/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/27/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/26/2022
EX2G
SOU EXTENSION 2 GRANTED
10/26/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/26/2022
IUAF
USE AMENDMENT FILED
10/17/2022
EXT2
SOU EXTENSION 2 FILED
10/17/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/17/2022
EISU
TEAS STATEMENT OF USE RECEIVED
10/17/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/04/2022
EX1G
SOU EXTENSION 1 GRANTED
05/02/2022
EXT1
SOU EXTENSION 1 FILED
05/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/02/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/02/2021
CHPB
POST PUBLICATION AMENDMENT - ENTERED
09/07/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2021
PUBO
PUBLISHED FOR OPPOSITION
09/07/2021
APET
ASSIGNED TO PETITION STAFF
08/25/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/18/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
08/15/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
07/28/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/28/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
07/28/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/28/2021
DOCK
ASSIGNED TO EXAMINER
07/20/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2021
NWAP
NEW APPLICATION ENTERED
01/14/2021
Continuous trademark protection
Get notified about every new filing that threatens ADAPTIVE BIOTECHNOLOGIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.